相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Lrp5 functions in bone to regulate bone mass
Yajun Cui et al.
NATURE MEDICINE (2011)
LRP4 Mutations Alter Wnt/β-Catenin Signaling and Cause Limb and Kidney Malformations in Cenani-Lenz Syndrome
Yun Li et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2010)
Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee
A. Michael Parfitt et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Osteocyte Wnt/β-Catenin Signaling Is Required for Normal Bone Homeostasis
Ina Kramer et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84
R. R. Recker et al.
BONE (2009)
Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts
Robert L. Jilka et al.
BONE (2009)
Lrp4, a Novel Receptor for Dickkopf 1 and Sclerostin, Is Expressed by Osteoblasts and Regulates Bone Growth and Turnover In Vivo
Hong Y. Choi et al.
PLOS ONE (2009)
Lrp5 Controls Bone Formation by Inhibiting Serotonin Synthesis in the Duodenum
Vijay K. Yadav et al.
CELL (2008)
Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes
Charles A. O'Brien et al.
PLOS ONE (2008)
Control of the SOST bone enhancer by PTH using MEF2 transcription factors
Olivier Leupin et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Effects of daily treatment with parathyroid hormone 1-84 for 16 months on density, architecture and biomechanical properties of cortical bone in adult ovariectomized rhesus monkeys
J. Fox et al.
BONE (2007)
Minireview:: Targeting the Wnt/β-catenin pathway to regulate bone formation in the adult skeleton
Roland Baron et al.
ENDOCRINOLOGY (2007)
Molecular and cellular mechanisms of the anabolic effect of intermittent PTH
Robert L. Jilka
BONE (2007)
Minireview:: In vivo analysis of Wnt signaling in bone
Donald A. Glass et al.
ENDOCRINOLOGY (2007)
Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium
Robert Lindsay et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity
Akiko Iida-Klein et al.
BONE (2007)
Wnt/β-catenin signaling is a normal physiological response to mechanical loading in bone
John A. Robinson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice
P Clément-Lacroix et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: A novel mechanism for hormonal control of osteoblastogenesis
T Bellido et al.
ENDOCRINOLOGY (2005)
SOST is a target gene for PTH in bone
H Keller et al.
BONE (2005)
Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease
GG Loots et al.
GENOME RESEARCH (2005)
Essential role of β-catenin in postnatal bone acquisition
SL Holmen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling
XF Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation
DA Glass et al.
DEVELOPMENTAL CELL (2005)
Constitutively active PTH/PTHrP receptor in odontoblasts alters odontoblast and ameloblast function and maturation
LM Calvi et al.
MECHANISMS OF DEVELOPMENT (2004)
Dentin matrix protein 1 expression during osteoblastic differentiation, generation of an osteocyte GFP-transgene
I Kalajzic et al.
BONE (2004)
Periosteum: biology, regulation, and response to osteoporosis therapies
MR Allen et al.
BONE (2004)
Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts - A putative explanation for why intermittent administration is needed for bone anabolism
T Bellido et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Bone loss and bone size after menopause
HG Ahlborg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Toward an expanded understanding of the role of the periosteum in skeletal health
ES Orwoll
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
DG Winkler et al.
EMBO JOURNAL (2003)
Parathyroid hormone stimulates receptor activator of NFκB ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein
Q Fu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Parathyroid hormone and periosteal bone expansion
AM Parfitt
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone
DD Bikle et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Pathogenesis of bone fragility in women and men
E Seeman
LANCET (2002)
The biomechanical basis of vertebral body fragility in men and women
YB Duan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Evidence that anabolic effects of PTH on bone require IGF-I in growing mice
N Miyakoshi et al.
ENDOCRINOLOGY (2001)
Intracapsular hip fracture and the region-specific loss of cortical bone: Analysis by peripheral quantitative computed tomography
N Crabtree et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Bone tissue and its mineralization in aged estrogen-depleted rats after long-term intermittent treatment with parathyroid hormone (PTH) analog SDZ PTS 893 or human PTH(1-34)
M Kneissel et al.
BONE (2001)
Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone
LM Calvi et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys
DB Burr et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Changes in geometry and cortical porosity in adult, ovary-intact rabbits after 5 months treatment with LY333334 (hPTH 1-34)
T Hirano et al.
CALCIFIED TISSUE INTERNATIONAL (2000)